Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia

NCT04529382 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT04529382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04529382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia
Lead sponsor
Leiden University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
December 17, 2019
Completion date
December 17, 2021
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal and neonatal alloimmune thrombocytopenia, intravenous immunoglobulin adverse reaction, long term adverse effects, neurodevelopmental abnormality